# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

B-Cell Lymphomas

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 541-550 of 562 results.
A Study to Assess Safety of ImbruvicaTM in Indian Participants With Chronic Lymphocytic Leukemia or Mantle Cell Lymphoma Who Have Received at Least One Prior Therapy or Chronic Lymphocytic Leukemia With 17p Deletion
Status: Recruiting
Last Changed: May 29, 2020
First Received: Jun 16, 2017
Disease(s): Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Mantle-Cell
Intervention(s): Ibrutinib 420 mg, Ibrutinib 560 mg
Locations: Vedanta Institute of Medical Science, Ahmedabad, India
Avron Hospitals Pvt. Ltd, Ahmedabad, India
Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India
Basavatarakam Indo-American Hospital, Hyderabad, India
Bhagwan Mahaveer Cancer Hospital & Research Centre, Jaipur, India
... and 9 other locations.
A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Status: Recruiting
Last Changed: Jul 23, 2020
First Received: Dec 24, 2019
Disease(s): Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell
Intervention(s): JNJ-64264681
Locations: Icahn School of Medicine at Mount Sinai, New York, New York, United States
Arensia Exploratory Medicine, Tbilisi, Georgia
Arensia Exploratory Medicine, Chisinau, Moldova, Republic of
Queen Mary University of London, Charterhouse Square, United Kingdom
St James University Hospital, Leeds, United Kingdom
... and 2 other locations.
Study of Brexucabtagene Autoleucel (KTE-X19) for the Treatment of Individuals With Relapsed/Refractory B-Cell Malignancies
Status: Available
Last Changed: Jul 29, 2020
First Received: Nov 14, 2019
Disease(s): Relapse/Refractory Mantle Cell Lymphoma
Intervention(s): Brexucabtagene Autoleucel (KTE-X19), Fludarabine, Cyclophosphamide
Locations: Stanford Cancer Institute, Stanford, California, United States
Colorado Blood Cancer Institute, Denver, Colorado, United States
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
Cleveland Clinic, Cleveland, Ohio, United States
... and 4 other locations.
Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma
Status: Recruiting
Last Changed: Nov 27, 2019
First Received: Apr 12, 2017
Disease(s): B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Hematopoietic/Lymphoid Cancer, Refractory Chronic Lymphocytic Leukemia
Intervention(s): anti-CD19 CAR-T, Fludarabine, Cyclophosphamide
Locations: The First Affilicated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Status: Recruiting
Last Changed: May 27, 2020
First Received: Dec 04, 2019
Disease(s): Non Hodgkin Lymphoma (NHL), Mantle Cell Lymphoma (MCL)
Intervention(s): 8-Day Production of Car-T Cells, 12-Day Production of Car-T Cells
Locations: Medical College of Wisconsin and Froedtert Hospital, Milwaukee, Wisconsin, United States
A Study of JNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)
Status: Recruiting
Last Changed: Jul 17, 2020
First Received: Apr 03, 2019
Disease(s): Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin
Intervention(s): JNJ-67856633
Locations: City of Hope, Duarte, California, United States
University of Nebraska Medical Center, Omaha, Nebraska, United States
Weill Cornell Medicine, New York, New York, United States
Icahn School of Medicine at Mount Sinai, New York, New York, United States
Memorial Sloan Kettering Cancer Center, New York, New York, United States
... and 28 other locations.
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Status: Recruiting
Last Changed: Sep 18, 2019
First Received: Sep 27, 2016
Disease(s): Lymphoma, Large B-Cell, Diffuse Large B-Cell
Intervention(s): R-CHOP with doxorubicin
Locations: U.O.C. Garibaldi Nesima, Catania, CT, Italy
Divisione di Ematologia, Centro Trapianto di Cellule Staminali, San Giovanni Rotondo, Foggia, Italy
AO Riuniti Papardo Piemonte, Messina, ME, Italy
Dipartimento di Oncologia Medica ed Ematologia Istituto Clinico Humanitas, Rozzano, Milano, Italy
Azienda Ospedaliera Ospedale Niguarda Ca' Granda, Milano, MI, Italy
... and 16 other locations.
In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies
Status: Recruiting
Last Changed: Feb 11, 2020
First Received: Sep 08, 2011
Disease(s): Acute Lymphocytic Leukemia, Lymphoma
Intervention(s): Biological/Genetically Modified T cells, Cyclophosphamide-based chemotherapy
Locations: Memorial Sloan Kettering Cancer Center, New York, New York, United States
The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies
Status: Recruiting
Last Changed: Dec 03, 2019
First Received: Dec 03, 2019
Disease(s): B Acute Lymphoblastic Leukemia, Mantle Cell Lymphoma, Follicular Lymphoma
Intervention(s): CD19-CART
Locations: Hematology Department of the Second Affiliated Hospital of Suzhou University, Suzhou, Jiangsu, China
Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies
Status: Recruiting
Last Changed: Jun 17, 2020
First Received: Dec 12, 2014
Disease(s): Follicular Lymphoma, ALL, NHL, Large Cell Lymphoma
Intervention(s): CD22-CAR
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States